官方服务：
资源简介：
IDENTIFICATION OF A NOVEL TRIM24-NTRK3 FUSION IN A CASE OF NON-SMALL-CELL LUNG CANCER
应用场景：
创建时间：
2020-11-18
相关数据集
Transcriptional and Epigenomic profile of GSK126 or dox-mediated Ezh2 inhibition in KrasG12D/+;Trp53-/-;Ezh2i-GFP-2A-rTA;Luc lung tumors in vivo. Mus musculus
We wanted to understand the consequences of GSK126-mediated Ezh2 inhibition in an orthotopic model of Kras-driven non-small cell lung cancer (NSCLC). We injected the NSCLC cells with above-mentioned g
NIAID Data Ecosystem120
The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC
Although epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) gefitinib has exhibited notable clinical efficacy in non-small cell lung cancer (NSCLC) patients. However, its therapeu
DataCite Commons2024-02-08 更新80
Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis
Non-small cell lung cancer (NSCLC) is the most common malignant tumor of lung, which seriously threatens the life of people. It has been reported that lncRNA prostate cancer-associated transcript 6 (P
DataCite Commons2024-03-22 更新40
Baseline characteristics of NSCLC patients and healthy subjects.
Baseline characteristics of NSCLC patients and healthy subjects.
NIAID Data Ecosystem80
Demographic characteristics of 36 patients with stage 4 NSCLC.
Demographic characteristics of 36 patients with stage 4 NSCLC.
Figshare2021-07-01 更新60
